2nd Annual UT Southwestern Multidisciplinary Endocrine Tumor Symposium: Mild Autonomous Cortisol Secretion And Primary Aldosteronism (RP2206E)
This live virtual CME activity is designed for physicians, nurses, and healthcare professionals in the specialties of surgery, endocrinology, medical oncology, radiation oncology, and medical oncology. Didactic presentations will provide a comprehensive review of Mild Autonomous Cortisol Secretion and Primary Aldosteronism . Case presentations will provide practical lessons in applying the current guidelines.
This CME activity is intended for providers in the specialties of: Endocrinology, Oncology (Medical), Otolaryngology, Radiation Oncology, Radiology, and Surgery - Oncology.
Professional Practice Gap:
The guidelines and clinical management of autonymous cortisol production and aldosterone production by the adrenal glands have evolved significantly over the past several years. For example, the bichemical diagnosis, investigation and subsequent treatmtent recommendations for a complex sepectrum of pateints continues to evolve. Ever-changing guidelines plus multiple different specialty providers involved in the treatment of adrenal patients (particularly where surgeons, endocrinologists and primary care providers may be primarily responsible for any given patient) increases inconsistencies and confusion in optimal care which negatively impacts patient outcomes.
Evaluate current and evolving guidelines in the work up and clinical management of patients with autonymous coritsol secretion and primary hyperaldosteronism. A. Specifics of biochemical diagnosis. B. Utility of Adrenal Vein Sampling C. Selection of patients for surgery vs medical management/monitoring.
1) Interpret current and evolving treatments guidelines and best practices for biochemical diagnosis;
2) Discuss current and emerging investigative imaging and interventional studies; and
3) Identify recommendations for surgical vs. medical management.
Expanded application of treatment guidelines and expert recommendations by the healthcare team to ensure data driven, standard of care is being administered to promote best patient outcomes.
CLICK ON A PRESENTATION TITLE TO VIEW PRESENTATION SLIDES HANDOUT
12:45 PM Attendees log on to Zoom
12:55 PM Welcome & Introductions
1:00 PM Mild Autonomous Cortisol Secretion in Adrenal Incidentalomoas: Why Should We Care? – Irina Bancos, MD
1:45 PM Q&A
2:00 PM A Rational Approach to the Occult Epidemic of Primary Aldosteronism – Richard J. Auchus, MD, PhD
2:45 PM Q&A
3:00 PM Clinical Case Presentations
3:55 PM Closing Remarks
4:00 PM Adjourn
DISCLOSURE OF FINANCIAL RELATIONSHIPS
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas Southwestern Medical Center designates this continuing education activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The University of Texas Southwestern Medical Center certifies that non-physicians will receive an attendance certificate stating that they participated in the activity that was designated for a maximum of 3.0 AMA PRA Category 1 Credits™.
- 3.00 AMA
- 3.00 Attendance
To register for this symposium, please email: Gabby.Hernandez@UTSouthwestern.edu
After attending the symposium:
All attendees will receive an email from the CME Office, with instructions and a link for: verifying attendance, accessing conference materials, completing the course evaluation, and claiming CME or Attendance credit..
REQUIREMENTS FOR COMPLETING THE COURSE:
- Attend the June 24, 2022 Live Virtual Session
- Complete the Course Evaluation
- Claim the number of credits/hours you participated and are claiming
Once all of these requirements are fulfilled, credits are posted to your Ethos account/activity transcript, and you may then view/download/print your CME/Attendance certificate.